Calidi Biotherapeutics (CLDI) Short Interest Ratio & Short Volume → Most important medical advance in 100 years (From The Oxford Club) (Ad) Free CLDI Stock Alerts $0.23 -0.01 (-5.99%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Calidi Biotherapeutics Short Interest DataCurrent Short Volume45,600 sharesPrevious Short Volume1,430,000 sharesChange Vs. Previous Month-96.81%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares35,730,000 sharesPercentage of Shares Shorted0.13%Today's Trading Volume211,700 sharesAverage Trading Volume717,057 sharesToday's Volume Vs. Average30% Short Selling Calidi Biotherapeutics ? Sign up to receive the latest short interest report for Calidi Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLDI Short Interest Over TimeCLDI Days to Cover Over TimeCLDI Percentage of Float Shorted Over Time Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Calidi Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202445,600 shares $0.00 -96.8%N/A0 $0.00 4/15/20241,430,000 shares $0.00 +859.7%N/A2.3 $0.00 3/31/2024149,000 shares $0.00 +1.2%N/A0.5 $0.00 3/15/2024147,300 shares $0.00 -52.6%N/A0.6 $0.00 2/29/2024310,600 shares $0.00 +0.3%N/A1.3 $0.00 2/15/2024309,700 shares $0.00 +143.1%N/A1.3 $0.00 1/31/2024127,400 shares $0.00 No ChangeN/A1.7 $0.00 CLDI Short Interest - Frequently Asked Questions What is Calidi Biotherapeutics' current short interest? Short interest is the volume of Calidi Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 45,600 shares of CLDI short. Learn More on Calidi Biotherapeutics' current short interest. Is Calidi Biotherapeutics' short interest increasing or decreasing? Calidi Biotherapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 45,600 shares, a decline of 96.8% from the previous total of 1,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Calidi Biotherapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Calidi Biotherapeutics: Enzon Pharmaceuticals, Inc. (0.00%), Genetic Technologies Limited (0.58%), Creative Medical Technology Holdings, Inc. (1.55%), Palisade Bio, Inc. (21.34%), Organovo Holdings, Inc. (4.09%), Titan Pharmaceuticals, Inc. (1.99%), Fresh Tracks Therapeutics, Inc. (0.17%), BioCardia, Inc. (0.96%), TRACON Pharmaceuticals, Inc. (7.29%), TC Biopharm (Holdings) Plc (5.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Calidi Biotherapeutics stock? Short selling CLDI is an investing strategy that aims to generate trading profit from Calidi Biotherapeutics as its price is falling. CLDI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calidi Biotherapeutics? A short squeeze for Calidi Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLDI, which in turn drives the price of the stock up even further. How often is Calidi Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLDI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ENZN Short Interest Data GENE Short Interest Data CELZ Short Interest Data PALI Short Interest Data ONVO Short Interest Data TTNP Short Interest Data FRTX Short Interest Data BCDA Short Interest Data TCON Short Interest Data TCBP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:CLDI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits